THOMAS FRANK E 4
4 · Orchard Therapeutics plc · Filed Mar 14, 2023
Insider Transaction Report
Form 4
THOMAS FRANK E
See Remarks
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-10$0.46/sh+20,000$9,182→ 92,081 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-03-10−20,000→ 335,000 totalExercise: $0.46Exp: 2032-05-31→ Ordinary Shares (20,000 underlying)
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents ten Ordinary Shares.
- [F2]The shares subject to this option vest and become exercisable in twenty-four (24) equal monthly installments, with the first installment vested on March 1, 2022.